Araki 1969 |
Uncontrolled trial |
Bernstein 1988 |
Open trial. 18 patients treated with auranofin over 24 weeks. Significant protection afforded against methacholine challenge but no changes in lung function. Reductions in steroid dose recorded. |
Dudan 1932 |
Uncontrolled trial. Parenteral gold, some benefits for reduction in bronchodilators and lung function |
Honma 1994 |
Double blind trial amongst 19 patients treated over 12 weeks. Excluded as group were not steroid dependent asthmatics. Reductions in airway responsiveness to methacholine noted in gold treated patients. |
Ishizaki 1965 |
Uncontrolled trial. |
McNeil 1989 |
Open trial. 8 patients treated for 7‐17 months with oral gold. Global improvements in asthma control but no change in lung function. Reductions in steroid doses recorded. |
Montagna 1936 |
Uncontrolled trial |
Muranaka 1978 |
Double blind trial amongst 79 patients treated with gold or placebo over 8 weeks. Excluded on the basis that the trial subjects were not all steroid dependent asthmatics. Of the subjects completing the trial, physician assessment of asthma control showed significant improvements in 20/28 gold treated patients and 16/36 placebo treated patients. |
Okatani 1970 |
Uncontrolled trial. Derived from data from over 1000 asthmatics treated over 14 years. |
Von Lebinski 1936 |
Uncontrolled trial. |